Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorine 18-labeled fluorodeoxyglucose Robert J. Gropler OriginalPaper Pages: S4 - S14
Assessment of myocardial fatty acid metabolism with 1-11C-palmitate Edward M. Geltman OriginalPaper Pages: S15 - S22
Imaging of myocardial sympathetic innervation with metaiodobenzylguanidine Michael W. Dae OriginalPaper Pages: S23 - S30
Viable but noncontractile myocardium: The clinical problem Attilio Maseri OriginalPaper Pages: S31 - S33
Investigation of myocardial metabolism for the study of the pathophysiology of cardiac disease Paolo G. Camici OriginalPaper Pages: S34 - S39
Current status of viability assessment with positron tomography Nagara Tamaki OriginalPaper Pages: S40 - S47
The use of carbon 11-labeled acetate for assessment of aerobic metabolism Jacques A. MelinJean -Louis VanoverscheldeWilliam Wijns OriginalPaper Pages: S48 - S57
Experimental and clinical experience with iodine 123-labeled iodophenylpentadecanoic acid in cardiology Sven N. Reske OriginalPaper Pages: S58 - S64
Clinical results with β-methyl-p-(123I)iodophenylpentadecanoic acid, single-photon emission computed tomography in cardiac disease Tsunehiko NishimuraToshiisa UeharaKazuo Haze OriginalPaper Pages: S65 - S71
The use of iodinated free fatty acids for assessing fatty acid metabolism Nagara TamakiMasahide Kawamoto OriginalPaper Pages: S72 - S78
Iodine 123-labeled metaiodobenzylguanidine imaging in heart disease Pascal MerletHéric ValetteAndré Syrota OriginalPaper Pages: S79 - S85
Merits and limitations of radionuclide approaches to viability and future developments Heinrich R. Schelbert OriginalPaper Pages: S86 - S96
